CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs

(2013) V. Beziat et al.   BLOOD

Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation

(2012) Margaret L. Green et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

CMV-specific cellular therapy for acute myeloid leukemia?

(2012) K. J. Thomson et al.   BLOOD

Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection

(2012) Hojjatollah N. Charoudeh et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients

(2011) A. H. Elmaagacli et al.   BLOOD

Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?

(2011) M. Della Chiesa et al.   BLOOD

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function

(2011) B. Foley et al.   BLOOD

Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma

(2011) Madhavi Challa-Malladi et al.   CANCER CELL

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

(2010) D. Grimwade et al.   BLOOD

Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy

(2010) B. George et al.   Transplant Infectious Disease

Donor and Recipient CMV Serostatus and Outcome of Pediatric Allogeneic HSCT for Acute Leukemia in the Era of CMV-Preemptive Therapy

(2009) Carolyn E. Behrendt et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation

(2009) L Farina et al.   LEUKEMIA